0000899243-19-017955.txt : 20190624 0000899243-19-017955.hdr.sgml : 20190624 20190624170419 ACCESSION NUMBER: 0000899243-19-017955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190624 DATE AS OF CHANGE: 20190624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGeorge Anne CENTRAL INDEX KEY: 0001779934 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38541 FILM NUMBER: 19916068 MAIL ADDRESS: STREET 1: C/O MAGENTA THERAPEUTICS, INC. STREET 2: 100 TECHNOLOGY SQUARE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Magenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-20 0 0001690585 Magenta Therapeutics, Inc. MGTA 0001779934 McGeorge Anne C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 14.94 2019-06-20 4 A 0 36377 0.00 A 2029-06-19 Common Stock 36377 36377 D This option shall vest and become exercisable over three years, with 33% of this option vesting on June 20, 2020, and the remainder vesting in 24 equal monthly installments thereafter. /s/ Zoran Zdraveski, Attorney-in-Fact for Anne McGeorge 2019-06-24